Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trulieve CannabisSTU:F09 61 EV-to-OCF is 9.02 as of Aug. 20, 2026, which is 60% below its 10-year median of 22.64. GuruFocus rates STU:F09 with a GF Score™ of 61/100 and a GF Value™ of €5.38 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Trulieve Cannabis ranks better than 55.32% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Trulieve Cannabis's Enterprise Value is €1,893.1 Mil.
Trulieve Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €210.0 Mil. Therefore, Trulieve Cannabis's EV-to-OCF for today is 9.02.
The historical rank and industry rank for Trulieve Cannabis's EV-to-OCF or its related term are showing as below:
STU:F09'
s EV-to-OCF Range Over the Past 10 Years
Min: -3003.33 Med: 22.64 Max: 444.47
Current: 8.65
During the past 10 years, the highest EV-to-OCF of Trulieve Cannabis was 444.47. The lowest was -3003.33. And the median was 22.64.
STU:F09's EV-to-OCF is ranked better than 55.32% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 10.86
vs STU:F09: 8.65
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trulieve Cannabis's PE Ratio (TTM) for today is calculated as:
Trulieve Cannabis's share price for today is €7.83.
Trulieve Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.121.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Trulieve Cannabis EV-to-OCF Related Terms
Trulieve Cannabis EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's EV-to-OCF falls into.
Trulieve Cannabis's current Enterprise Value is €1,893.1 Mil.
Trulieve Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €210.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (STU:F09) has a EV-to-OCF of 9.02 as of Aug. 20, 2026. This is 60% below median its historical median of 22.64. According to the industry distribution chart, Trulieve Cannabis ranks #449 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 44.7%.
Is Trulieve Cannabis' EV-to-OCF too high?
Trulieve Cannabis' current EV-to-OCF of 9.02 is 60% below median its 10-year median of 22.64. The Drug Manufacturers industry median EV-to-OCF is 10.86. Trulieve Cannabis' value of 9.02 is 16.9% below this industry median. Based on the distribution chart, Trulieve Cannabis ranks #449 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Trulieve Cannabis has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' EV-to-OCF compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #449 out of 1005 companies for EV-to-OCF. This puts Trulieve Cannabis in the upper half of its industry. The industry median EV-to-OCF is 10.86. Trulieve Cannabis' value of 9.02 is 16.9% below this benchmark. While the company's 10-year median is 22.64 vs. the industry median of 10.86, Trulieve Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.86, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trulieve Cannabis's current EV-to-OCF of 9.02 is 16.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current EV-to-OCF is 9.02, which is 60% below median its own 10-year median of 22.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (STU:F09) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.38, compared to a current price of €7.83 — trading 45.5% above its estimated fair value. The current EV-to-OCF is 9.02, which is 60% below median its 10-year median of 22.64 and 16.9% below the Drug Manufacturers industry median of 10.86. Trulieve Cannabis' overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Trulieve Cannabis (STU:F09), the current EV-to-OCF is 9.02 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (STU:F09) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €7.83 is trading 45.5% above its estimated GF Value™ of €5.38.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for STU:F09:
EV-to-OCF: 9.02 (60% below median its 10-year median of 22.64)
GF Value™: €5.38 vs. price of €7.83 (45.5% above fair value)
Industry Position: 16.9% below the Drug Manufacturers median (#449 of 1005)
No single metric tells the full story. See the STU:F09 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
61GF Score
Get the complete analysis for STU:F09
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:F09 has been successfully added to your 
